aluminum oxide has been researched along with Centriacinar Emphysema in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aschner, M; Chen, R; Chen, W; Cui, J; Li, X; Lu, R; Meng, Q; Sun, H; Wu, S; Yang, H; Zhang, R; Zheng, Y | 1 |
1 other study(ies) available for aluminum oxide and Centriacinar Emphysema
Article | Year |
---|---|
Suppression of PTPN6 exacerbates aluminum oxide nanoparticle-induced COPD-like lesions in mice through activation of STAT pathway.
Topics: A549 Cells; Aluminum Oxide; Animals; Apoptosis; Apoptosis Regulatory Proteins; Disease Progression; Dose-Response Relationship, Drug; Humans; Inflammation Mediators; Inhalation Exposure; Lung; Male; Metal Nanoparticles; Mice, Inbred C57BL; Phosphorylation; Pneumonia; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; RNA-Binding Proteins; Signal Transduction; STAT3 Transcription Factor; Time Factors | 2017 |